Trade Summary

3 days ago, Opaleye Management Inc., serving as 10% owner Owner at Eton Pharmaceuticals, Inc. (ETON), sold 28,315 shares at $37.54 per share, for a total transaction value of $1,063,032.88. Following this transaction, Opaleye Management Inc. now holds 40,000 shares of ETON.

This sale represents a 41.45% decrease in Opaleye Management Inc.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, July 14, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 16, 2026 at 5:14 PM ET, 2 days after the trade was made.

Eton Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.